Interim Meeting

Business of the AMA House of Delegates Interim Meeting

Resolutions and reports

Access reports and resolutions considered by the House as well as reference committee reports and final actions—as they become available.

Interim Meeting of the House of Delegates

Stay current on meeting information, agenda, and more.

Go to Meeting Site

Materials presented at the HOD Interim Meeting are generated by AMA delegates/delegations, the AMA Board of Trustees, AMA Councils and AMA Sections.

*DISCLAIMER: Readers of this material are reminded that it refers only to items to be considered by the House. No action has been taken on anything herein contained and it is informational only. Only those items that have been acted upon by the House can be considered official.

All resolutions submitted for consideration at the 2019 Interim Meeting are subject to review by the Resolution Committee which is responsible for reviewing resolutions to determine their compliance with the meeting’s focus on advocacy and related issues.

Resolutions

Resolution 001 - Support for the Use of Psychiatric Advance Directives*

Resolution 002 - Endorsing the Creation of a Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Research IRB Program*

Resolution 003 - Accurate Collection of Preferred Language and Disaggregated Race and Ethnicity to Characterize Health Disparities*

Resolution 004 - Improving Inclusiveness of Transgender Patients Within Electronic Medical Record Systems*

Resolution 005 - Removing Sex Designation from the Public Portion of the Birth Certificate*

Resolution 006 - Transparency Improving Informed Consent for Reproductive Health Services*

Resolution 007 - Addressing the Racial Pay Gap in Medicine*

Resolution 008 - Improving the Health and Safety of Consensual Sex Workers*

Resolution 009 - Data for Specialty Society Five-Year Review*

Resolution 010 - Ban Conversion Therapy of LGBTQ Youth*

Resolution 011 - End Child Marriage*

Resolution 201 - Advocating for the Standardization and Regulation of Outpatient Addiction Rehabilitation Facilities*

Resolution 202 - Support for Veterans Courts*

Resolution 203 - Support Expansion of Good Samaritan Laws*

Resolution 204 - AMA Position on Payment Provisions in Health Insurance Policies*

Resolution 205 -Co-Pay Accumulators*

Resolution 206 - Improvement of Healthcare Access in Underserved Areas by Retaining and Incentivizing IMG Physicians*

Resolution 207 - Pharmaceutical Advertising in Electronic Health Record Systems*

Resolution 208 - Net Neutrality and Public Health*

Resolution 209 - Federal Government Regulation and Promoting Patient Access to Kidney Transplantation

Resolution 210 - Federal Government Regulation and Promoting Renal Transplantation*

Resolution 211 - Effects of Net Neutrality on Public Health*

Resolution 212 - Centers for Medicare and Medicaid Services Open Payments Program*

Resolution 213 - Data Completeness and the House of Medicine*

Resolution 301 - Engaging Stakeholders for Establishment of a Two-Interval, or Pass/Fail, Grading System of Non-Clinical Curriculum in U.S. Medical Schools*

Resolution 302 - Strengthening Standards for LGBTQ Medical Education*

Resolution 303 - Investigation of Existing Application Barriers for Osteopathic Medical Students Applying for Away Rotations*

Resolution 304 - Issues with the Match, The National Residency Matching Program (NRMP)*

Resolution 305 - Ensuring Access to Safe and Quality Care for our Veterans*

Resolution 306 - Financial Burden of USMLE Step 2 CS on Medical Students*

Resolution 307 - Implementation of Financial Education Curriculum for Students and Physicians in Training*

Resolution 308 - Study Expediting Entry of Qualified IMG Physicians to US Medical Practice*

Resolution 601 - Amending G-630.140, Lodging, Meeting Venues, and Social Functions*

Resolution 801 - Reimbursement for Post-Exposure Protocol for Needlestick Injuries*

Resolution 802 - Ensuring Fair Pricing of Drugs Developed with the United States Government*

Resolution 803 - Encourage Federal Efforts to Expand Access to Scheduled Dialysis for Undocumented People*

Resolution 804 - Protecting Seniors from Medicare Advantage Plans*

Resolution 805 - Fair Medication Pricing for Patients in United States: Advocating for a Global Pricing Standard*

Resolution 806 - Support for Housing Modification Policies*

Resolution 807 - Addressing the Need for Low Vision Aid Devices*

Resolution 808 - Protecting Patient Access to Seat Elevation and Standing Features in Power Wheelchairs*

Resolution 809 - AMA Principles of Medicaid Reform*

Resolution 810 - Hospital Medical Staff Policy*

Resolution 811 - Require Payers to Share Prior Authorization Cost Burden*

Resolution 901 - Health Impact of Per- and Polyfluoroalkyl Substances (PFAS) Contamination in Drinking Water*

Resolution 902 - Amending H-490.913, Smoke-Free Environments and Workplaces, and H-409.907, Tobacco Smoke Exposure of Children in Multi-Unit Housing, to Include E-Cigarettes*

Resolution 903 - Encouraging the Development of Multi-Language, Culturally Informed Mobile Health Applications*

Resolution 904 - Amendment to H-150.949, Healthy Food Options in Hospitals*

Resolution 905 - Sunscreen Dispensers in Public Spaces as a Public Health Measure*

Resolution 906 - Ensuring the Best In-School Care for Children with Sickle Cell Disease*

Resolution 907 - Increasing Access to Gang-Related Laser Tattoo Removal in Prison and Community Settings*

Resolution 908 - Request for Benzodiazepine-Specific Prescribing Guidelines for Physicians*

Resolution 909 - Decreasing the Use of Oximetry Monitors for the Prevention of Sudden Infant Death Syndrome*

Resolution 910 - Ban on Electronic Nicotine Delivery System (ENDS) Products*

Resolution 911 - Basic Courses in Nutrition*

Resolution 912 - Improving Emergency Response Planning for Infectious Disease Outbreaks*

Resolution 913 - Public Health Impacts and Unintended Consequences of Legalization and Decriminalization of Cannabis for Medicinal and Recreational Use*

Resolution 914 - Nicotine Replacement Therapy for Minors*

Resolution 915 - Preventing Death and Disability Due to Particulate Matter Produced by Automobiles*

Resolution 916 - Sale of Tobacco in Retail Pharmacies*

Resolution 917 - Supporting Research into the Therapeutic Potential of Psychedelics*

Resolution 918 - Banning Flavors, Including Menthol and Mint, in Combustible and Electronic Cigarettes and Other Nicotine Products*

Resolution 919 - Raising Awareness of the Health Impact of Cannabis*

Resolution 921 - Vaping in New York State and Nationally*

Resolution 922 - Understanding the Effects of PFAS on Human Health*

Resolution 923 - Support Availability of Public Transit System*

Resolution 924 - Update Scheduled Medication Classification*

Board and Council Reports

BOT 01 - Legalization of the Deferred Action for Legal Childhood Arrival (DALCA)*

BOT 02 - Enabling Methadone Treatment of Opioid Use Disorder in Primary Care Settings*

BOT 03 - Restriction on IMG Moonlighting*

BOT 04 - Involvement of Women in AMA Leadership, Recognition and Research Opportunities*

BOT 05 - Restrictive Covenants of Large Health Care Systems*

BOT 06 - Physician Health Policy Opportunity*

BOT 07 - 2019 AMA Advocacy Efforts*

BOT 08 - Implementing AMA Climate Change Principles Through JAMA Paper Consumption Reduction and Green Health Care Leadership*

BOT 09 - Opioid Mitigation*

BOT 10 - Childcare at AMA HOD Meetings*

BOT 11 - Re-establishment of National Guideline Clearinghouse*

BOT 12 - Distracted Driver Education and Advocacy*

BOT 13 - Hospital Closures and Physician Credentialing*

BOT 14 - Redefining the AMA's Position on ACA and Healthcare Reform*

CCB 01 - Parity in our House of Delegates*

CCB 03 - AMA Delegate Apportionment*

CEJA 01 - Competence, Self-Assessment and Self-Awareness*

CEJA 02 - Amendment to E-1.2.2., "Disruptive Behavior by Patients"*

CLRPD 01 - Academic Physicians Sections Five-Year Review*

CMS 01 - Established Patient Relationships and Telemedicine*

CMS 02 - Addressing Financial Incentives to Shop for Lower-Cost Health Care*

CMS 03 - Improving Risk Adjustment in Alternative Payment Models*

CMS 04 - Mechanisms to Address High and Escalating Pharmaceutical Prices*

CSAPH 01 - Mandatory Reporting of Diseases and Conditions*

CSAPH 02 - Real-World Data and Real-World Evidence in Medical Product Decision Making*

CSAPH 03 - Patient Use of Non-FDA Approved Cannabis and Cannabinoid Products in Hospitals*